In vitro metabolism of 6-mercaptopurine by human liver cytosol.
1. The aim of this study was to investigate 6-mercaptopurine (6MP) metabolism by human liver cytosol in vitro. 2. Cytosol was prepared from seven human livers (A-G). A single cytosol (C) was used to optimize incubation conditions. 3. Cytosols A-G were incubated with 6MP at 2, 10 and 500 microM for two fixed times (5 and 48 h). Parent drug, thiopurine and thionucleotide metabolites were quantitated by high performance liquid chromatography at all time points. 4. At 5 and 48 h the 2 microM and 10 microM 6MP incubations contained both 6MP and its initial nucleotide metabolite, thioinosine 5'-monophosphate (TIMP). In addition, the 10 microM 6MP 48 h incubates contained small amounts of 6-thioguanine (6TG, median 0.12 microM). At 500 microM 6MP all seven liver incubates produced a range of metabolites. At 48 h these included thiouric acid, 8-hydroxy-6-mercaptopurine and 6-methylmercaptopurine (median 31, 19.5 and 8.8 microM respectively), with TIMP, 6TG, thioxanthine and thioxanthine nucleotide at median concentrations of 61, 0.79, 2.11 and 0.80 microM respectively. Thioguanine nucleotides, major metabolites measured in vivo, were not detected. 5. These results indicate that the human liver 6MP metabolic profile is dependent upon drug concentration.
Rowland
K
K
University of Sheffield, Division of Clinical Sciences (CSUH), Royal Hallamshire Hospital, UK.
Lennard
L
L
Lilleyman
J S
JS
D000964:Antimetabolites, Antineoplastic / Q000378:metabolism*; D001711:Biotransformation; D002458:Cell Fractionation; D002851:Chromatography, High Pressure Liquid; D003600:Cytosol / Q000378:metabolism*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008099:Liver / Q000378:metabolism*; D008297:Male; D015122:Mercaptopurine / Q000378:metabolism*; D008875:Middle Aged
D000964:Antimetabolites, Antineoplastic; D015122:Mercaptopurine